| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 67028 |
Intravitreal injection of a pharmacologic agent |
23,720 |
21,882 |
$1.59M |
| J9035 |
Injection, bevacizumab, 10 mg |
15,563 |
14,318 |
$1.28M |
| 92134 |
|
46,537 |
43,452 |
$1.14M |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
10,502 |
10,083 |
$806K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
9,742 |
9,155 |
$472K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,543 |
2,442 |
$204K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,731 |
3,543 |
$201K |
| J2778 |
Injection, ranibizumab, 0.1 mg |
121 |
107 |
$99K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,562 |
2,413 |
$89K |
| 92201 |
|
4,241 |
4,155 |
$70K |
| J0178 |
Injection, aflibercept, 1 mg |
43 |
41 |
$48K |
| 92235 |
|
764 |
732 |
$46K |
| 92250 |
|
1,193 |
1,126 |
$39K |
| 92226 |
|
1,792 |
1,158 |
$21K |
| 92225 |
|
1,239 |
779 |
$16K |
| J7999 |
Compounded drug, not otherwise classified |
244 |
212 |
$7K |
| 92202 |
|
551 |
537 |
$5K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
43 |
42 |
$5K |
| 76512 |
|
70 |
61 |
$3K |
| 92083 |
|
12 |
12 |
$576.61 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
362 |
329 |
$29.56 |